Cargando…
CABG versus PCI: What is the optimal strategy for multi-vessel disease?
Autores principales: | Kumar, Ayush, Priya, Khatri, Govinda, Hasan, Mohammad Mehedi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486619/ https://www.ncbi.nlm.nih.gov/pubmed/36147185 http://dx.doi.org/10.1016/j.amsu.2022.104354 |
Ejemplares similares
-
Statins: Masked anti-epileptic warriors
por: Khatri, Govinda, et al.
Publicado: (2022) -
Hydrochlorothiazide: A savior to the heart or a foe to the skin?
por: Kumar, Ayush, et al.
Publicado: (2022) -
Evidence based decision making between PCI and CABG
por: Collet, Carlos
Publicado: (2019) -
Long-Term Mortality of 306,868 Patients with Multi-Vessel Coronary Artery Disease: CABG versus PCI
por: Efird, Jimmy T., et al.
Publicado: (2013) -
PCI or CABG, That is the Question!
por: Woo, Jong Shin, et al.
Publicado: (2017)